Related Experiment Video
Updated: Feb 2, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
Piao Huang1, Rong Yan1, Xue Zhang1
1Center for Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China.
Abstract:
Wnt/β-catenin signaling pathway is essential for embryo development and adult tissue homeostasis and regeneration, abnormal regulation of the pathway is tightly associated with many disease types, suggesting that Wnt/β-catenin signaling pathway is an attractive target for disease therapy. While the Wnt inhibitors have been extensively reviewed, small molecules activating Wnt/β-catenin signaling were rarely addressed. In this article, we firstly reviewed the diseases that were associated with disruption of Wnt/β-catenin signaling pathway, including hair loss, pigmentary disorders, wound healing, bone diseases, neurodegenerative diseases and chronic obstructive pulmonary diseases, etc. We also comprehensively summarized small molecules that activated Wnt/β-catenin signaling pathway in various models in vitro and in vivo. To evaluate the therapeutic potential of Wnt activation, we focused on the discovery strategies, phenotypic characterization, and target identification of the Wnt activators. Finally, we proposed the challenges and opportunities in development of Wnt activators for pharmacological agents in term of targeting safety and selectivity.
Insights
Small molecules that activate the Wnt/β-catenin signaling pathway are crucial for development and tissue repair. This review details Wnt activators, their therapeutic potential in diseases like hair loss and neurodegeneration, and future development challenges.
Area of Science:
- Molecular Biology
- Biochemistry
- Pharmacology
Background:
- The Wnt/β-catenin signaling pathway is vital for embryonic development, tissue homeostasis, and regeneration.
- Dysregulation of this pathway is linked to various diseases, making it a key therapeutic target.
- While Wnt inhibitors are well-studied, small molecules that activate Wnt signaling remain less explored.
Purpose of the Study:
- To review diseases associated with Wnt/β-catenin signaling pathway disruption.
- To comprehensively summarize small molecules that activate Wnt/β-catenin signaling.
- To evaluate the therapeutic potential of Wnt activators by focusing on discovery, characterization, and target identification.
Main Methods:
- Literature review of diseases linked to Wnt/β-catenin signaling.
- Comprehensive summary of small molecules activating Wnt/β-catenin signaling in vitro and in vivo models.
- Analysis of Wnt activator discovery strategies, phenotypic characterization, and target identification.
Main Results:
- Identified numerous diseases associated with Wnt/β-catenin pathway disruption, including hair loss, pigmentary disorders, wound healing, bone diseases, neurodegenerative diseases, and COPD.
- Compiled a comprehensive list of small molecules known to activate Wnt/β-catenin signaling.
- Evaluated the therapeutic potential and discovery approaches for these Wnt activators.
Conclusions:
- Wnt/β-catenin signaling activators hold significant therapeutic promise for a range of diseases.
- Further research is needed to address challenges in targeting safety and selectivity for pharmacological development.
- This review provides a foundation for future drug development targeting Wnt pathway activation.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
TGF - β Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway

